Avanos Medical Inc (NYSE:AVNS) Holdings Raised by Great West Life Assurance Co. Can
Great West Life Assurance Co. Can grew its holdings in Avanos Medical Inc (NYSE:AVNS) by 4.2% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 29,681 shares of the company’s stock after acquiring an additional 1,210 shares during the quarter. Great West Life Assurance Co. Can’s holdings in Avanos Medical were worth $1,266,000 at the end of the most recent reporting period.
Other institutional investors have also made changes to their positions in the company. Bank of Montreal Can increased its holdings in shares of Avanos Medical by 26.7% in the fourth quarter. Bank of Montreal Can now owns 3,648 shares of the company’s stock worth $164,000 after acquiring an additional 768 shares in the last quarter. Suntrust Banks Inc. increased its holdings in shares of Avanos Medical by 32.6% in the fourth quarter. Suntrust Banks Inc. now owns 5,080 shares of the company’s stock worth $228,000 after acquiring an additional 1,248 shares in the last quarter. Advisor Group Inc. increased its holdings in shares of Avanos Medical by 64.4% in the fourth quarter. Advisor Group Inc. now owns 5,414 shares of the company’s stock worth $242,000 after acquiring an additional 2,120 shares in the last quarter. LS Investment Advisors LLC increased its holdings in shares of Avanos Medical by 89.3% in the fourth quarter. LS Investment Advisors LLC now owns 5,659 shares of the company’s stock worth $253,000 after acquiring an additional 2,670 shares in the last quarter. Finally, Brinker Capital Inc. bought a new stake in shares of Avanos Medical in the first quarter worth about $256,000. Institutional investors own 93.44% of the company’s stock.
In other news, CEO Joseph Fralin Woody acquired 3,500 shares of the firm’s stock in a transaction that occurred on Thursday, May 30th. The stock was acquired at an average cost of $39.95 per share, for a total transaction of $139,825.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.57% of the stock is currently owned by company insiders.
Avanos Medical (NYSE:AVNS) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $0.15 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.17 by ($0.02). The firm had revenue of $164.20 million for the quarter, compared to the consensus estimate of $163.72 million. Avanos Medical had a return on equity of 4.92% and a net margin of 2.58%. The firm’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.76 earnings per share. On average, research analysts predict that Avanos Medical Inc will post 1.24 earnings per share for the current year.
AVNS has been the subject of several recent analyst reports. Zacks Investment Research upgraded Avanos Medical from a “sell” rating to a “hold” rating in a report on Monday, March 25th. ValuEngine downgraded Avanos Medical from a “buy” rating to a “hold” rating in a report on Monday, March 11th. KeyCorp lowered their price target on Avanos Medical from $67.00 to $65.00 and set an “overweight” rating for the company in a report on Wednesday, February 27th. Finally, Morgan Stanley set a $47.00 price objective on Avanos Medical and gave the stock a “sell” rating in a report on Wednesday, May 8th. Three research analysts have rated the stock with a sell rating, one has given a hold rating and two have given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $63.00.
About Avanos Medical
Avanos Medical, Inc operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes.
Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical Inc (NYSE:AVNS).
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.